Enigma Diagnostics
The UK firm has purchased the assets for Enigma Diagnostics and anticipates it will soon receive clearance to market its first test for TB in China.
Enigma Selling Point-of-Care Dx Tech
The UK-based firm is selling technology underlying its point-of-care molecular diagnostics platform, the Enigma MiniLab.
NEW YORK (GenomeWeb) — Researchers at Johns Hopkins University have performed the first validation of the Cepheid Xpert Flu assay in a population of emergency room patients with acute undifferentiated respiratory illness.